Monday 28 August 2017

Risk factor driven upstream AF therapy improves sinus rhythm (RACE 3)

(European Society of Cardiology) Risk factor driven upstream rhythm control is effective, feasible and safe in improving maintenance of sinus rhythm in patients with early short lasting atrial fibrillation (AF) and heart failure, according to late-breaking results from the RACE 3 trial presented today in a Hot Line - LBCT Session at ESC Congress.1 The novel therapy included meticulous treatment of risk factors and change of lifestyle and was superior to conventional guideline recommended rhythm control.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2vkVbda

No comments:

Post a Comment